Apoptosis-related factors (TRAIL, DR4, DR5, DcRl, DcR2, apoptotic cells) and proliferative activity in ameloblastomas

Anticancer Research

Volumn 29, Issue 4, 2009, Pages 1137-1142

  Rizzardi, Clara ^a   Leocata, Pietro ^b   Ventura, Luca ^c   Zweyer, Marina ^a   Brollo, Alessandro ^d   Schneider, Manuela ^d   Melato, Mauro ^a,e  

^a UNIVERSITY OF TRIESTE   (Italy)

^b UNIVERSITY OF L'AQUILA   (Italy)

^c 4 L'Aquila   (Italy)

^d ASS n 2 Isontina   (Italy)

^e UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Ameloblastoma; Apoptosis; Proliferation; TNF related apoptosis inducing ligand

Indexed keywords

DEATH RECEPTOR 4; KI 67 ANTIGEN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND RECEPTOR;

ADULT; AMELOBLASTOMA; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMELOBLASTOMA; APOPTOSIS; CELL PROLIFERATION; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IN SITU NICK-END LABELING; MALE; MIDDLE AGED; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, MEMBER 10C; TNF-RELATED APOPTOSIS-INDUCING LIGAND; YOUNG ADULT;

EID: 64949088230     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Almasan A and Ashkenazi A: Apo2L/TRAIL: apoptosis signaling, biology, and potential for cancer therapy. Cytokine Growth Factor Rev 14: 337-348, 2003.
2. Kumamoto H: Detection of apoptosis-related factors and apoptotic cells in ameloblastomas: analysis by immunohistochemistry and an in situ DNA nick end-labelling method. J Oral Pathol Med 26: 419-425, 1997.
3. Kumamoto H, Kimi K and Ooya K: Immunohistochemical analysis of apoptosis-related factors (Fas, Fas ligand, caspase-3 and single-stranded DNA) in ameloblastomas. J Oral Pathol Med 30: 596-602,2001.
4. Kumamoto H and Ooya K: Immunohistochemical and ultrastructural investigation of apoptotic cell death in granular cell ameloblastoma. J Oral Pathol Med 30: 245-250, 2001.
5. Sandra F, Mitsuyasu T, Nakamura N, Shiratsuchi Y and Ohishi M: Immunohistochemical evaluation of PCNA and Ki-67 in ameloblastoma. Oral Oncol 37: 193-198, 2001.
6. Kumamoto H and Ooya K: Expression of tumor necrosis factor a, TNF-related apoptosis-inducing ligand, and their associated molecules in ameloblastomas. J Oral Pathol Med 34: 287-294, 2005.
7. Meer S, Galpin JS, Altini M, Coleman H and Ali H: Proliferating cell nuclear antigen and Ki67 immunoreactivity in ameloblastomas. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 95: 213-221,2003.
8. Piattelli A, Fioroni M, Santinelli A and Rubini C: Expression of proliferating cell nuclear antigen in ameloblastomas and odontogenic cysts. Oral Oncol 34: 408-412, 1998.
9. Ong'uti MN, Cruchley AT, Howells GL and Williams DM: Ki- 67 antigen in ameloblastomas: correlation with clinical and histological parameters in 54 cases from Kenya. Int J Oral Maxillofac Surg 26: 376-379, 1997.
10. Funaoka K, Arisue M, Kobayashi I, Iizuka T, Kohgo T, Amemiya A and Totsuka Y: Immunohistochemical detection of proliferating cell nuclear antigen (PCNA) in 23 cases of ameloblastoma. Eur J Cancer B Oral Oncol 32B: 328-332,1996.
11. Li TJ, Browne RM and Matthews JB: Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in unicystic ameloblastoma. Histopathology 26: 219-228, 1995.
12. Kim J and Yook JI: Immunohistochemical study on proliferating cell nuclear antigen expression in ameloblastomas. Eur J Cancer B Oral Oncol 30B: 126-131, 1994.
13. Gardner DG, Heikinheimo K, Shear M, Philipsen HP and Coleman H: Ameloblastomas. In: World Health Organization Classification of Tumors. Pathology and Genetics of Head and Neck Tumors. Barnes L, Eveson IW, Reichart P and Sidransky D (eds.). Lyon, IARCPress, pp. 296-300, 2005.
14. Sandra F, Hendarmin L, Nakao Y, Ohishi M and Nakamura N: TRAIL cleaves caspase-8, -9 and -3 of AM-1 cells: a possible pathway for TRAIL to induce apoptosis in ameloblastoma. Tumor Biol 26: 258-264, 2005.
15. Sandra F, Hendarmin L and Nakamura S: Osteoprotegerin (OPG) binds with tumor necrosis factor-related apoptosis- inducing ligand (TRAIL): suppression of TRAIL-induced apoptosis in ameloblastomas. Oral Oncol 42: 415-420, 2006.
16. Sandra F, Nakamura N, Mitsuyasu T, Shiratsuchi Y and Ohishi M: Two relatively distinct patterns of ameloblastoma: an anti- apoptotic proliferating site in the outer layer (periphery) and a pro-apoptotic differentiating site in the inner layer (centre). Histopathology 39: 93-98, 2001.
17. Rosenstein T, Pogrel MA, Smith RA and Regezi JA: Cystic ameloblastoma. Behavior and treatment of 21 cases. J Oral Maxillofac Surg 59: 1311-1316, 2001.